Potential Role of Sorafenib as Neoadjuvant Therapy in Unresectable Papillary Thyroid Cancer

Archives of endocrinology and metabolism - Brazil
doi 10.20945/2359-3997000000046
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Archives of Endocrinology and Metabolism

Related search

Rethinking the Role of Oncogenes in Papillary Thyroid Cancer Initiation

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2012English

5‑Hydroxymethylcytosine as a Potential Epigenetic Biomarker in Papillary Thyroid Carcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Transferrin Receptor-Targeted HMSN for Sorafenib Delivery in Refractory Differentiated Thyroid Cancer Therapy

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

Papillary Thyroid Cancer in Three Children

Pediatric Endocrinology, Diabetes and Metabolism
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2019English

Adjuvant Treatment With Biphosponates in Complex Therapy of Papillary Thyroid Cancer Bone Metastases

Research'n Practical Medicine Journal
2017English

Serum Biomarkers of Papillary Thyroid Cancer

Journal of Otolaryngology - Head and Neck Surgery
OtorhinolaryngologySurgery
2013English

Phase II Trial of Sorafenib in Advanced Thyroid Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Radioiodine Therapy of Papillary Thyroid Cancer, Complicated by a Radial Myelitis. Clinical Case

The Russian Archives of Internal Medicine
2018English

Neoadjuvant Endocrine Therapy in Breast Cancer: Current Role and Future Perspectives

ecancermedicalscience
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy